Plenty Of Potential For Roche's Entrectinib Despite Lack Of ESMO Enthusiasm

 
• By Kevin Grogan
Star Trek
Set Phasers to Stun: Solid data from entrectinib's STARTRK trials • Source: Shutterstock

More from Clinical Trials

More from R&D